XML 41 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements Of Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative effect of change in accounting principle
Common Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss, Net
Retained Earnings
Retained Earnings
Cumulative effect of change in accounting principle
Noncontrolling Interests
Balance at beginning of period (in shares) at Dec. 31, 2019     44,676,000          
Balance at beginning of period at Dec. 31, 2019 $ 380,326 $ (1,871) $ 447 $ 332,109 $ (77,887) $ 125,763 $ (1,871) $ (106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common shares for share-based compensation, net of forfeitures (in shares)     286,000          
Issuance of common shares for share-based compensation, net of forfeitures 274   $ 3 271        
Share-based compensation expense 5,193     5,193        
Tax payments related to share-based compensation (5,515)     (5,515)        
Unrealized loss on interest rate derivatives, interest rate swap and foreign currency forward contracts, net of deferred income tax benefit (39,842)       (39,842)      
Net income attributable to controlling interests 5,755         5,755    
Net loss attributable to noncontrolling interests (6)             (6)
Foreign currency translation adjustments, net of deferred income tax benefit (19,582)       (19,620) (3)   41
Repurchase of common shares (in shares)     (506,000)          
Repurchase of common shares (16,873)   $ (5) (3,530)   (13,338)    
Balance at end of period (in shares) at Mar. 31, 2020     44,456,000          
Balance at end of period at Mar. 31, 2020 307,859   $ 445 328,528 (137,349) 116,306   (71)
Balance at beginning of period (in shares) at Dec. 31, 2019     44,676,000          
Balance at beginning of period at Dec. 31, 2019 380,326 $ (1,871) $ 447 332,109 (77,887) 125,763 $ (1,871) (106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income attributable to controlling interests $ 19,144              
Balance at end of period (in shares) at Dec. 31, 2020 44,539,433   44,539,000          
Balance at end of period at Dec. 31, 2020 $ 379,416   $ 445 343,042 (93,731) 129,693   (33)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common shares for share-based compensation, net of forfeitures (in shares)     717,000          
Issuance of common shares for share-based compensation, net of forfeitures 768   $ 8 760        
Share-based compensation expense 4,258     4,258        
Tax payments related to share-based compensation (14,464)     (14,464)        
Unrealized loss on interest rate derivatives, interest rate swap and foreign currency forward contracts, net of deferred income tax benefit 15,064       15,064      
Net income attributable to controlling interests 5,876         5,876    
Net loss attributable to noncontrolling interests (3)             (3)
Foreign currency translation adjustments, net of deferred income tax benefit $ 2,541       2,605 (1)   (63)
Balance at end of period (in shares) at Mar. 31, 2021 45,255,680   45,256,000          
Balance at end of period at Mar. 31, 2021 $ 393,456   $ 453 $ 333,596 $ (76,062) $ 135,568   $ (99)